Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern ; volume:23 ; number:1 ; day:13 ; month:5 ; year:2023 ; pages:1-16 ; date:12.2023
BMC cancer ; 23, Heft 1 (13.5.2023), 1-16, 12.2023

Creator: Dietsch, Bianca
Weller, Céline
Sticht, Carsten
Torre, Carolina de la
Kramer, Martin
Goerdt, Sergij
Géraud, Cyrill
Wohlfeil, Sebastian A.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12885-023-10912-4

URN: urn:nbn:de:101:1-2023090812295302041078

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Other Objects (12)

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Inhibition and degradation of NRAS with a pan-NRAS monobody

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences

Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

$Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Inhibition and degradation of NRAS with a pan-NRAS monobody

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences

Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

$Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Inhibition and degradation of NRAS with a pan-NRAS monobody

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences

Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

$Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Inhibition and degradation of NRAS with a pan-NRAS monobody

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences

Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Inhibition and degradation of NRAS with a pan-NRAS monobody

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences

Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Inhibition and degradation of NRAS with a pan-NRAS monobody

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences

Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Related objects

Reset password